Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension

OBJECTIVE: Pulmonary arterial hypertension (PAH), caused by pulmonary artery remodelling and increased pulmonary vascular resistance (PVR) due to an unknown mechanism, is an intractable disease with a poor prognosis. The recent development of PAH-specific treatment medications may allow for higher P...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Sho, Asano, Ryotaro, Aoki, Tatsuo, Nakayama, Sayuri, Ueda, Jin, Tsuji, Akihiro, Noguchi, Teruo, Ogo, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pulmonary Vascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185661/
https://www.ncbi.nlm.nih.gov/pubmed/35675988
http://dx.doi.org/10.1136/openhrt-2022-002054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185661/
https://www.ncbi.nlm.nih.gov/pubmed/35675988
http://dx.doi.org/10.1136/openhrt-2022-002054

Ejemplares similares